WRBYWarby Parker Inc.
$25.30-11% 1Y
$25.30
$16.4952 weeks$30.23
Latest close: back above its 200-day averageOct 9, 2026what changed →
The financials
Warby Parker Inc. by the numbers
Warby Parker Inc. (WRBY) reported revenue of $236M in Q2 2026 (quarter ended Jun 30, 2026), up 9.8% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $4.6M (2.0% of revenue). For the full year FY2025, revenue was $872M (+13% year on year) and net income $1.6M. Its largest product in Q2 2026 was Eyewear Products at $192M, 81% of the disclosed total, well ahead of Contacts at 11%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $236M | $214M | +9.8% |
| Gross profit | $136M | $114M | +20% |
| Operating income | $3.2M | −$4.5M | to a profit |
| Net income | $4.6M | −$1.8M | to a profit |
| Diluted EPS | $0.04 | −$0.01 | to a profit |
| Product | Revenue | Share |
|---|---|---|
| Eyewear Products | $192M | 81% |
| Contacts | $27M | 11% |
| Eye Care | $17M | 7.3% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $235.5M (-2.9%)
Eye Care grew +32% year on yearContacts +7.9% year on year
Segment Latestquarter on quarteryear on year
- Eyewear Products$191.8M$191.8Mquarter on quarter -4.8%year on year +8.4%-4.8%+8.4%
- Contacts$26.6M$26.6Mquarter on quarter +10.0%year on year +7.9%+10.0%+7.9%
- Eye Care$17.2M$17.2Mquarter on quarter +2.0%year on year +32%+2.0%+32%
On our screens:Most shorted stocks
Medical Instruments & Supplies
Ranks #19 of 21 by RyuScore